Sector
PharmaceuticalsOpen
₹284.95Prev. Close
₹281.5Turnover(Lac.)
₹16.65Day's High
₹284.95Day's Low
₹27052 Week's High
₹39852 Week's Low
₹173.3Book Value
₹100.49Face Value
₹10Mkt Cap (₹ Cr.)
89.78P/E
15.32EPS
18.38Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 3.18 | 3.18 | 3.18 | 3.18 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 28.76 | 23.64 | 18.36 | 16.69 |
Net Worth | 31.94 | 26.82 | 21.54 | 19.87 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 22.67 | 21.28 | 16.59 | 15.44 |
yoy growth (%) | 6.55 | 28.24 | 7.45 | 0.7 |
Raw materials | -10.72 | -9.27 | -7.74 | -6.76 |
As % of sales | 47.29 | 43.56 | 46.64 | 43.79 |
Employee costs | -3.88 | -3.48 | -2.72 | -3.06 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 3.96 | 3.9 | 9.36 | 1.14 |
Depreciation | -0.05 | -0.02 | -0.31 | -0.55 |
Tax paid | -1.02 | -0.91 | -2.53 | -0.68 |
Working capital | -6.69 | 2.44 | 9.78 | -1.16 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 6.55 | 28.24 | 7.45 | 0.7 |
Op profit growth | 7.74 | 57.95 | 9.86 | 28.16 |
EBIT growth | 1.01 | -58.6 | 531.49 | 58.04 |
Net profit growth | -1.76 | -54.16 | 1,311.97 | 95.49 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,781.65 | 155.06 | 4,27,477.51 | 863.29 | 0.76 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,171.05 | 89.18 | 1,63,821.99 | 518 | 0.49 | 2,302 | 513.62 |
Cipla Ltd CIPLA | 1,534.4 | 29.27 | 1,23,920.06 | 1,178.16 | 0.85 | 3,969.86 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,326.9 | 68.82 | 1,12,592.36 | 460 | 0.84 | 2,376 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,562.25 | 51.21 | 1,02,659.66 | 634.43 | 0 | 2,529.74 | 269.23 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole Time Director
Sunil Jain Kumar.
Whole Time Director
Sanjay Kumar Jain.
Managing Director
Rajesh Pokerna
Whole Time Director
Seema Jain
Independent Non Exe. Director
Pradeep Kumar Jain
Independent Non Exe. Director
Pravichandra Majumdar Popatlal
Independent Non Exe. Director
Rajiv Kakodkar
Independent Non Exe. Director
Manish Jain
Whole Time Director
Manish Kumar Jain
Company Sec. & Compli. Officer
Santosh Kumar Jha
Independent Non Exe. Director
Vinod Kumar Jain
Independent Non Exe. Director
Ashok Kumar Jain
Independent Non Exe. Director
Kodakandla Sudarshanam
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Vasundhara Rasayans Ltd
Summary
Vasundhara Rasayans Limited was incorporated in March, 1987. The Company is the leading manufacturer and exporter of Antacids therapeutic category of Active Pharmaceutical Ingredients with annual capacity of about 1500 MT of powder or its equivalent products. It started its operation in year 1990 with an Antacid API facility offering product in paste, powder and micronised grade of powder. The plant is located on National Highway between Mumbai and Goa in an Industrial Zone called Mahad which is about 170 KMS from Mumbai and about 125 KMS from the NSICT /JNPT Ports Mumbai. In addition to the API manufacturing Vasundhara is also having an API intermediate plant to handle organic products with its state of the art specialised Friedel Craft reaction facility. The manufacturing area is maintained as per GMP standards. In addition to the standard set of machinery required for production of consistent quality, efficient and smooth flow production process the heart of the production plant is the Spray Drier. It is a totally closed system that prevents any contamination and complies with GMP requirements. Air coming in contact with the product in spray drier is passed through micron filter & then heated indirectly to more than 300 DEG C. The high temperature air and the instant drying in a closed system helps to have minimum microbial contamination and any foreign matter during the drying which is the most common issues with the Antacid API. The atomizer helps to produce product wi
Read More
The Vasundhara Rasayans Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹282.5 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vasundhara Rasayans Ltd is ₹89.78 Cr. as of 02 Dec ‘24
The PE and PB ratios of Vasundhara Rasayans Ltd is 15.32 and 2.80 as of 02 Dec ‘24
The 52-week high/low is the highest and lowest price at which a Vasundhara Rasayans Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vasundhara Rasayans Ltd is ₹173.3 and ₹398 as of 02 Dec ‘24
Vasundhara Rasayans Ltd's CAGR for 5 Years at 61.09%, 3 Years at 36.19%, 1 Year at 41.96%, 6 Month at 22.66%, 3 Month at -8.16% and 1 Month at 7.10%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice